Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Spinal Muscular Atrophy Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Spinal Muscular Atrophy Treatment Market, by Product, 2019-2029 (USD Billion)
1.2.3. Spinal Muscular Atrophy Treatment Market, by Disease Type, 2019-2029 (USD Billion)
1.2.4. Spinal Muscular Atrophy Treatment Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Spinal Muscular Atrophy Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Spinal Muscular Atrophy Treatment Market Dynamics
3.1. Spinal Muscular Atrophy Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing awareness regarding novel therapies
3.1.1.2. Growing prevalence of spinal muscular atrophy
3.1.2. Market Challenges
3.1.2.1. High costs associated with the approved products
3.1.2.2. Dearth of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Introduction of new product with high efficacies
3.1.3.2. Growing R&D investments
Chapter 4. Global Spinal Muscular Atrophy Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Spinal Muscular Atrophy Treatment Market, by Product
6.1. Market Snapshot
6.2. Global Spinal Muscular Atrophy Treatment Market by Product, Performance - Potential Analysis
6.3. Global Spinal Muscular Atrophy Treatment Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Spinal Muscular Atrophy Treatment Market, Sub Segment Analysis
6.4.1. Nusinersen
6.4.2. Onasemnogen Abeparvovec
Chapter 7. Global Spinal Muscular Atrophy Treatment Market, by Disease Type
7.1. Market Snapshot
7.2. Global Spinal Muscular Atrophy Treatment Market by Disease Type, Performance - Potential Analysis
7.3. Global Spinal Muscular Atrophy Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
7.4. Spinal Muscular Atrophy Treatment Market, Sub Segment Analysis
7.4.1. Type 1 SMA
7.4.2. Type 2 SMA
7.4.3. Others
Chapter 8. Global Spinal Muscular Atrophy Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Spinal Muscular Atrophy Treatment Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Spinal Muscular Atrophy Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Spinal Muscular Atrophy Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Others
Chapter 9. Global Spinal Muscular Atrophy Treatment Market, Regional Analysis
9.1. Spinal Muscular Atrophy Treatment Market, Regional Market Snapshot
9.2. North America Spinal Muscular Atrophy Treatment Market
9.2.1. U.S. Spinal Muscular Atrophy Treatment Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Spinal Muscular Atrophy Treatment Market
9.3. Europe Spinal Muscular Atrophy Treatment Market Snapshot
9.3.1. U.K. Spinal Muscular Atrophy Treatment Market
9.3.2. Germany Spinal Muscular Atrophy Treatment Market
9.3.3. France Spinal Muscular Atrophy Treatment Market
9.3.4. Spain Spinal Muscular Atrophy Treatment Market
9.3.5. Italy Spinal Muscular Atrophy Treatment Market
9.3.6. Rest of Europe Spinal Muscular Atrophy Treatment Market
9.4. Asia-Pacific Spinal Muscular Atrophy Treatment Market Snapshot
9.4.1. China Spinal Muscular Atrophy Treatment Market
9.4.2. India Spinal Muscular Atrophy Treatment Market
9.4.3. Japan Spinal Muscular Atrophy Treatment Market
9.4.4. Australia Spinal Muscular Atrophy Treatment Market
9.4.5. South Korea Spinal Muscular Atrophy Treatment Market
9.4.6. Rest of Asia Pacific Spinal Muscular Atrophy Treatment Market
9.5. Latin America Spinal Muscular Atrophy Treatment Market Snapshot
9.5.1. Brazil Spinal Muscular Atrophy Treatment Market
9.5.2. Mexico Spinal Muscular Atrophy Treatment Market
9.5.3. Rest of Latin America Spinal Muscular Atrophy Treatment Market
9.6. Rest of The World Spinal Muscular Atrophy Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Biogen
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novartis AG
10.2.3. Ionis Pharmaceuticals Inc.
10.2.4. Biohaven Pharmaceuticals
10.2.5. F. Hoffmann-La Roche Ltd
10.2.6. Cytokinetics
10.2.7. Scholar Rock, Inc.
10.2.8. PTC Therapeutics
10.2.9. NMD PHARMA A/S
10.2.10. Astellas Pharma Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption